Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats

Takuya Kishi, Yoshitaka Hirooka, Hiroaki Shimokawa, Akira Takeshita, Kenji Sunagawa

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Previously, we demonstrated that atorvastatin has sympatho-inhibitory effects with the upregulation of nitric oxide synthase in the brain in stroke-prone spontaneously hypertensive rats (SHRSP), and that reactive oxygen species in the rostral ventrolateral medulla (RVLM), where the vasomotor center is located, mediate the sympatho-excitatory effect. The aim of the present study was to determine if atorvastatin reduces oxidative stress in the RVLM of SHRSP along with the sympatho-inhibitory effect. SHRSP and Wistar-Kyoto (WKY) rats received standard feed with atorvastatin (50mg/kg per day) or standard feed for 30 days. Systolic blood pressure and heart rate were evaluated using the tail-cuff method. Urinary norepinephrine excretion was measured for 24 hours. After 30 days in SHRSP, blood pressure and urinary norepinephrine excretion were significantly lower in the atorvastatin group than in the control group. Thiobarbituric acid-reactive substance (TBARS) levels in the RVLM tissue obtained using the micropunch technique were used as measures of oxidative stress. Prior to the treatment, TBARS levels in the RVLM of SHRSP were significantly higher than those of WKY. After 30 days, TBARS levels in the RVLM of SHRSP were significantly lower in the atorvastatin group than in the control group. After 30 days in WKY, however, there were no differences in blood pressure, urinary norepinephrine excretion, and TBARS levels between the atorvastatin and control groups. These results suggest that atorvastatin reduces oxidative stress in the RVLM of SHRSP, which might contribute to the sympatho-inhibitory effects of atorvastatin in SHRSP.

Original languageEnglish
Pages (from-to)3-11
Number of pages9
JournalClinical and Experimental Hypertension
Volume30
Issue number1
DOIs
Publication statusPublished - Jan 1 2008

Fingerprint

Inbred SHR Rats
Oxidative Stress
Stroke
Thiobarbituric Acid Reactive Substances
Blood Pressure
Norepinephrine
Control Groups
Inbred WKY Rats
Atorvastatin Calcium
Nitric Oxide Synthase
Tail
Reactive Oxygen Species
Up-Regulation
Heart Rate
Brain

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology

Cite this

Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. / Kishi, Takuya; Hirooka, Yoshitaka; Shimokawa, Hiroaki; Takeshita, Akira; Sunagawa, Kenji.

In: Clinical and Experimental Hypertension, Vol. 30, No. 1, 01.01.2008, p. 3-11.

Research output: Contribution to journalArticle

Kishi, Takuya ; Hirooka, Yoshitaka ; Shimokawa, Hiroaki ; Takeshita, Akira ; Sunagawa, Kenji. / Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. In: Clinical and Experimental Hypertension. 2008 ; Vol. 30, No. 1. pp. 3-11.
@article{7d867684b0904636b845e1adad2275f4,
title = "Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats",
abstract = "Previously, we demonstrated that atorvastatin has sympatho-inhibitory effects with the upregulation of nitric oxide synthase in the brain in stroke-prone spontaneously hypertensive rats (SHRSP), and that reactive oxygen species in the rostral ventrolateral medulla (RVLM), where the vasomotor center is located, mediate the sympatho-excitatory effect. The aim of the present study was to determine if atorvastatin reduces oxidative stress in the RVLM of SHRSP along with the sympatho-inhibitory effect. SHRSP and Wistar-Kyoto (WKY) rats received standard feed with atorvastatin (50mg/kg per day) or standard feed for 30 days. Systolic blood pressure and heart rate were evaluated using the tail-cuff method. Urinary norepinephrine excretion was measured for 24 hours. After 30 days in SHRSP, blood pressure and urinary norepinephrine excretion were significantly lower in the atorvastatin group than in the control group. Thiobarbituric acid-reactive substance (TBARS) levels in the RVLM tissue obtained using the micropunch technique were used as measures of oxidative stress. Prior to the treatment, TBARS levels in the RVLM of SHRSP were significantly higher than those of WKY. After 30 days, TBARS levels in the RVLM of SHRSP were significantly lower in the atorvastatin group than in the control group. After 30 days in WKY, however, there were no differences in blood pressure, urinary norepinephrine excretion, and TBARS levels between the atorvastatin and control groups. These results suggest that atorvastatin reduces oxidative stress in the RVLM of SHRSP, which might contribute to the sympatho-inhibitory effects of atorvastatin in SHRSP.",
author = "Takuya Kishi and Yoshitaka Hirooka and Hiroaki Shimokawa and Akira Takeshita and Kenji Sunagawa",
year = "2008",
month = "1",
day = "1",
doi = "10.1080/10641960701813429",
language = "English",
volume = "30",
pages = "3--11",
journal = "Clinical and Experimental Hypertension",
issn = "1064-1963",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Atorvastatin reduces oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats

AU - Kishi, Takuya

AU - Hirooka, Yoshitaka

AU - Shimokawa, Hiroaki

AU - Takeshita, Akira

AU - Sunagawa, Kenji

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Previously, we demonstrated that atorvastatin has sympatho-inhibitory effects with the upregulation of nitric oxide synthase in the brain in stroke-prone spontaneously hypertensive rats (SHRSP), and that reactive oxygen species in the rostral ventrolateral medulla (RVLM), where the vasomotor center is located, mediate the sympatho-excitatory effect. The aim of the present study was to determine if atorvastatin reduces oxidative stress in the RVLM of SHRSP along with the sympatho-inhibitory effect. SHRSP and Wistar-Kyoto (WKY) rats received standard feed with atorvastatin (50mg/kg per day) or standard feed for 30 days. Systolic blood pressure and heart rate were evaluated using the tail-cuff method. Urinary norepinephrine excretion was measured for 24 hours. After 30 days in SHRSP, blood pressure and urinary norepinephrine excretion were significantly lower in the atorvastatin group than in the control group. Thiobarbituric acid-reactive substance (TBARS) levels in the RVLM tissue obtained using the micropunch technique were used as measures of oxidative stress. Prior to the treatment, TBARS levels in the RVLM of SHRSP were significantly higher than those of WKY. After 30 days, TBARS levels in the RVLM of SHRSP were significantly lower in the atorvastatin group than in the control group. After 30 days in WKY, however, there were no differences in blood pressure, urinary norepinephrine excretion, and TBARS levels between the atorvastatin and control groups. These results suggest that atorvastatin reduces oxidative stress in the RVLM of SHRSP, which might contribute to the sympatho-inhibitory effects of atorvastatin in SHRSP.

AB - Previously, we demonstrated that atorvastatin has sympatho-inhibitory effects with the upregulation of nitric oxide synthase in the brain in stroke-prone spontaneously hypertensive rats (SHRSP), and that reactive oxygen species in the rostral ventrolateral medulla (RVLM), where the vasomotor center is located, mediate the sympatho-excitatory effect. The aim of the present study was to determine if atorvastatin reduces oxidative stress in the RVLM of SHRSP along with the sympatho-inhibitory effect. SHRSP and Wistar-Kyoto (WKY) rats received standard feed with atorvastatin (50mg/kg per day) or standard feed for 30 days. Systolic blood pressure and heart rate were evaluated using the tail-cuff method. Urinary norepinephrine excretion was measured for 24 hours. After 30 days in SHRSP, blood pressure and urinary norepinephrine excretion were significantly lower in the atorvastatin group than in the control group. Thiobarbituric acid-reactive substance (TBARS) levels in the RVLM tissue obtained using the micropunch technique were used as measures of oxidative stress. Prior to the treatment, TBARS levels in the RVLM of SHRSP were significantly higher than those of WKY. After 30 days, TBARS levels in the RVLM of SHRSP were significantly lower in the atorvastatin group than in the control group. After 30 days in WKY, however, there were no differences in blood pressure, urinary norepinephrine excretion, and TBARS levels between the atorvastatin and control groups. These results suggest that atorvastatin reduces oxidative stress in the RVLM of SHRSP, which might contribute to the sympatho-inhibitory effects of atorvastatin in SHRSP.

UR - http://www.scopus.com/inward/record.url?scp=38549092439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38549092439&partnerID=8YFLogxK

U2 - 10.1080/10641960701813429

DO - 10.1080/10641960701813429

M3 - Article

C2 - 18214729

AN - SCOPUS:38549092439

VL - 30

SP - 3

EP - 11

JO - Clinical and Experimental Hypertension

JF - Clinical and Experimental Hypertension

SN - 1064-1963

IS - 1

ER -